Thu.Jul 13, 2023

article thumbnail

Utilizing AI for Medication Management

Drug Topics

Pharmacists can utilize AI for medication management and to prevent medication errors.

457
457
article thumbnail

Novo’s workhorse Ozempic could shine in new areas

PharmaVoice

Besides its popularity as a weight loss drug, Ozempic and treatments like it are being investigated for Alzheimer’s, liver disease and other surprising indications.

130
130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FDA Approves First OTC Birth Control Pill in United States

Drug Topics

The approval of norgestrel (Opill) is expected to help reduce barriers to access by allowing people to obtain the medication without needing to see a health care provider.

FDA 247
article thumbnail

FDA Approves First Nonprescription Daily Birth Control Pill

Pharmacy Times

The approval of norgestrel tablets (Opill) could open the door to other prescription-to-OTC contraceptive switches, although that remains to be seen as other pharmaceutical companies weigh their options.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Express Scripts Adds Cyltezo to National Preferred Formulary

Drug Topics

The news comes almost 2 weeks after Cyltezo’s entrance into the US biosimilars market as the first commercially available and FDA-approved interchangeable adalimumab biosimilar.

FDA 247
article thumbnail

Notable ASCO Trial Data Have the Potential to Transform Oncology Pharmacy Practice

Pharmacy Times

These study results may inform clinical practice strategies this year and beyond.

123
123

More Trending

article thumbnail

Study: Eating 6 Key Healthy Foods Found to Lower Risk for Cardiovascular Disease

Pharmacy Times

Impact of healthy eating was especially evident in countries where consumption of these foods is low, which elevates the risk for cardiovascular disease, including heart attacks and strokes.

123
123
article thumbnail

Doctors use precision medicine to show melanoma drugs can shrink rare brain tumor by 90%

STAT

By going down to the molecular level, doctors have uncovered a way to treat tumors caused by a rare brain cancer using medicines that already exist. Two cancer drugs — currently approved for the treatment of melanoma — were able to treat a rare type of brain cancer called PCP, or papillary craniopharyngioma, researchers reported in a study published Thursday in the New England Journal of Medicine.

98
article thumbnail

A Guide to Administering Influenza Vaccines in Special Populations: Focus on Patients Who Are Immunocompromised

Pharmacy Times

Expanding pharmacist–patient care services to include vaccine promotion and administration within ambulatory clinics is an example of the expanding role of pharmacists and their contribution to primary care practice.

Vaccines 123
article thumbnail

After FDA nod, Better Therapeutics races to boost dwindling cash

STAT

You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences.  Sign up to get this newsletter  delivered in your inbox every Tuesday and Thursday.

FDA 98
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

New, Accurate Detection Methods Necessary for Treating C. Difficile Infections

Pharmacy Times

MicroRNA has shown the potential to more effectively and accurately identify C. difficile infections and manage it after diagnosis.

123
123
article thumbnail

WHO says aspartame might cause cancer — but that most adult consumers don’t need to worry

STAT

WASHINGTON — Aspartame, the popular artificial sweetener in diet sodas and chewing gums, may possibly cause cancer — but the risk appears to be very low for occasional consumers of these products, according to two reports released Thursday evening by the World Health Organization. The first report , penned by the WHO’s International Agency for Research on Cancer (IARC), found “limited evidence” that aspartame may cause liver cancer.

98
article thumbnail

Abivertinib Shows Promise Treating Marginal Zone Lymphoma

Pharmacy Times

Irreversible Bruton tyrosine kinase inhibitor produces positive results in patients with relapsed/refractory marginal zone lymphoma.

123
123
article thumbnail

Why more Americans aren’t using the 988 mental-health crisis hotline

STAT

It’s been a year since the U.S. launched its 988 national mental health hotline — and while the service is still dealing with logistical challenges , its biggest issue may be persuading more Americans to make use of it. Only 33% of Americans are at least somewhat familiar with the number and the service it provides, according to a survey of more than 2,000 adults conducted by Ipsos and the National Alliance on Mental Illness (NAMI) conducted in June 2023.

98
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Role of Immunomodulatory Treatments in Drug-Induced Stevens John Syndrome, Toxic Epidermal Necrolysis Not Supported by Robust Evidence

Pharmacy Times

Evidence remains limited for specific therapies to treat the disease, but new clinical trials are ongoing.

123
123
article thumbnail

Opinion: Right-wing politicians are stoking renewed moral panic about HIV

STAT

In May, just before Pride Month, the Centers for Disease Control and Prevention released news worth celebrating: 2021 saw the  lowest numbers  of new HIV diagnoses in decades. New HIV infections were down 12% from 2017 to 2021, thanks to successful prevention efforts, including PrEP. The end of the epidemic may finally be in our grasp. Prevention methods now include a medication called PrEP (for pre-exposure prophylaxis), and uptake has never been higher.

98
article thumbnail

Constipation: When Should Patients Self-Treat or Seek Medical Care?

Pharmacy Times

Chronic or recurring episodes can lead to other complications.

122
122
article thumbnail

FDA approves first over-the-counter birth control pill

STAT

In a highly anticipated move, the Food and Drug Administration on Thursday approved the first over-the-counter birth control pill , a decision that could transform the way contraception is delivered in the United States. For the first time, people will now be able to readily purchase birth control online and at pharmacies, convenience stores, and grocery stores without a prescription, a requirement that has been seen as a hurdle to greater access to contraception.

article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Blood Plasma Proteins Could Aid Long Covid

Pharmacy Times

A potential new drug therapy found from blood proteins could improve outcomes for individuals diagnosed with long COVID.

116
116
article thumbnail

12 Questions with Chih Han Chen

pharmaphorum

12 Questions with Chih Han Chen Mike.

98
article thumbnail

STAT+: More hospitals are billing patients as online messages surge

STAT

Health systems drowning in messages from patients are grasping for new ways to manage the deluge — including charging for especially time-consuming responses. In recent months, health systems including Cleveland Clinic and University of Washington have trotted out new billing policies for when patient portal questions require more than just a few minutes of a provider’s time — an attempt to compensate for staff time spent while also stanching the breakneck response pace pati

article thumbnail

How can PAT help advance biologics manufacturing?

European Pharmaceutical Review

In EPR’s Future of Bio/Pharmaceutical Analysis online summit last month, Lonza’s Associate Director of R&D discussed the benefits and challenges of using process analytical technology (PAT) in biologics manufacturing. The CDMO’s Carrie Mason shared that PAT, “takes a little bit more time and more effort and more capital to set up in the beginning, but once you get it up and running it’s very continuous and it should continue to provide results for a long time”.

98
article thumbnail

Opinion: Health care systems must stop exploiting nurses’ tender hearts and begin supporting them

STAT

“C ode yellow!” someone screamed. I dipped in and out of consciousness, in and out of panic.

98
article thumbnail

These 10 drugs account for 22% of Medicare Part D spending: KFF

Fierce Healthcare

Approximately 22% of gross Medicare Part D spending can be attributed to 10 top-selling prescription drugs, according to analysis from KFF. | A new analysis shows a small number of prescription drugs disproportionately make up Medicare Part D spending.

98
article thumbnail

Three reasons why Chuck Schumer’s crusade against Logan Paul’s energy drink will likely fizzle out

STAT

WASHINGTON — Sen. Chuck Schumer (D-N.Y.), the most powerful person in the U.S. Senate, wants the Food and Drug Administration to investigate the increasingly popular energy drink brand Prime. But it’s unclear what grounds the FDA would have to single out the company in the near future, or what the agency could really do on its own if it wanted to take serious actions against its co-founder, social media star and professional wrestler Logan Paul.

FDA 98
article thumbnail

Medicare proposes coverage for PrEP without patient cost sharing

Fierce Healthcare

The Centers for Medicare & Medicaid Services (CMS) is recommending preexposure prophylaxis (PrEP) with oral or injectable antiretroviral therapy to people at risk of HIV without patient cost sh | A new proposal would allow Medicare beneficiaries to protect themselves against HIV without cost-sharing through preexposure prophylaxis and antiretroviral therapy.

98
article thumbnail

STAT+: Flagship recruits former BMS, Celgene R&D chief Rupert Vessey

STAT

After leaving his post as the head of research at Bristol Myers Squibb, Rupert Vessey is joining venture firm Flagship Pioneering. Vessey will become an executive partner and chief scientist at Flagship starting July 31, according to a press release. He will work with the teams at Flagship that create new startups, helping them with science and R&D strategies.

98
article thumbnail

Hospital M&A deal volume returns to pre-pandemic levels as systems seek out complementary services

Fierce Healthcare

Hospital merger and acquisition deal volume has returned to pre-pandemic levels as of the second quarter of 2023, according to a new roundup report. | Twenty new hospital merger and acquisition deals were unveiled during the second quarter of 2023, the most since 2018.

article thumbnail

Living in a historically redlined area linked to worse heart health, study finds

STAT

In the 1930s, the U.S. government introduced the practice of redlining — categorizing neighborhoods based on the ethnic and racial backgrounds of the people who lived there, with areas primarily occupied by people of color identified as high-risk for mortgage lenders. The policy led to further housing segregation and decades of disinvestment in health care, schools, and other basic services and infrastructure, taking a disproportionate toll on Black communities.

98
article thumbnail

Boost Post vs Creating Ads on Facebook

Pharma Marketing Network

When it comes to marketing your pharma business on Facebook, you may be wondering whether you should boost a post or create an ad. Both have their own advantages and disadvantages, so it’s important to choose the right option for your needs. Boosting a post is a quick and easy way to get more exposure for your content. When you boost a post, you’re essentially paying to increase its reach and visibility.

98
article thumbnail

STAT+: There’s a bill well-suited for drug shortage reforms, but Congress isn’t interested

STAT

WASHINGTON — Congress is considering a must-pass pandemic preparedness bill that presents a good opportunity to fix the nation’s current drug shortages problem, which both parties want to do. But most indications are that lawmakers will let that opportunity pass them by. Although not new, drug shortages are now a crisis, with an increasing number of reports about cancer doctors having to ration chemotherapies and other drugs.

article thumbnail

Re-engineering proteins to develop novel immunotherapies

European Pharmaceutical Review

The field of immunotherapy is constantly evolving with the ultimate goal to develop new treatments that help the body’s immune system fight cancer. Immune cells, such as T cells and natural killer (NK) cells, have the inherent ability to combat diseases, including cancer, but are often inhibited by the body’s own suppressive mechanisms. Cancer immunotherapies such as checkpoint inhibitors (CPIs) were designed to counteract these.

article thumbnail

STAT+: How a key Senate committee is planning to regulate pharmacy benefit managers

STAT

WASHINGTON — A key Senate health care panel has developed a plan to tackle reforms to middlemen in the pharmacy drug payment system, according to bill text obtained by STAT. The draft legislation, authored by Senate Finance Chair Ron Wyden (D-Ore.) and ranking member Mike Crapo (R-Idaho), includes several measures to regulate how pharmacy benefit managers are paid by health plans to negotiate with drugmakers.

98